Another company involved in using AI to repurpose failed drugs – as well as drugs that have already been approved – is ...

In the sixth episode of The Deep End, listen to what’s next for Jon Nelson and for deep brain stimulation research for depression.

As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's rapid-growth life sciences division. Previously, Guillen served as a Board ...